12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks showed notable movements. Gainers included 180 Life Sciences, ABVC BioPharma, Medpace Holdings, Adverum Biotechnologies, Black Diamond Therapeutic, and Verve Therapeutics, with increases ranging from 4.94% to 7.4%. On the losing side, Fresh2 Group, Kiora Pharmaceuticals, Alterity Therapeutics, Tiziana Life Sciences, Calidi Biotherapeutics, and Nuwellis saw declines between 7.06% and 12.9%. Medpace Holdings' stock rise followed their Q1 earnings release.
April 23, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Fresh2 Group shares fell 12.9% to $0.39, with a market cap of $9.6 million.
The sharp decline in Fresh2 Group's stock price could indicate negative investor sentiment, potentially leading to a negative short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 90
NEGATIVE IMPACT
Kiora Pharmaceuticals stock fell 12.66% to $0.51, with a market value of $13.3 million.
Kiora Pharmaceuticals' significant after-market drop suggests a negative market reaction, likely affecting the stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 90
POSITIVE IMPACT
ABVC BioPharma shares rose 5.22% to $1.42, with a market cap of $15.0 million.
The increase in ABVC BioPharma's stock price indicates a positive market reaction, likely to influence short-term trading positively.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 90
POSITIVE IMPACT
180 Life Sciences shares increased by 7.4% to $2.04, with a market value of $1.7 million.
The significant after-market gain suggests positive investor sentiment, potentially impacting short-term stock performance positively.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 90
POSITIVE IMPACT
Medpace Holdings' stock increased by 5.15% to $427.5, following their Q1 earnings release. The company's market cap is $13.2 billion.
The positive response to Medpace Holdings' Q1 earnings suggests strong investor confidence, likely leading to a favorable short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 95